Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
To the Editor.— As an investigator whose
research1 evaluating the effects of fluoxetine
(Prozac) exposure on pregnancy outcomes was misrepresented in the letter by
Dr Yonkers and colleagues,2 I am concerned
that health care practitioners might be misled, resulting in harm to patients.
Yonkers and colleagues ignored the interpretations and conclusions of other
such as Chambers et al, who noted that "the rate of spontaneous pregnancy
loss did not differ significantly between women treated with fluoxetine and
Goldstein DJ. Use of Serotonin Reuptake Inhibitors by Women of Childbearing Potential. JAMA. 1998;279(23):1873–1874. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-23-jbk0617
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: